Abstract: The present disclosure provides a polycaprolactone composition or polycaprolactone that includes a reaction product of (i) one or more cyclic aliphatic initiator and (ii) one or more unsubstituted or substitute caprolactone monomer, wherein (a) the one or more cyclic aliphatic initiator is present in the range of about 1.0 wt % to about 95.0 wt %, (b) the one or more caprolactone monomer is present in the range of about 5.0 wt % to about 99.0 wt %, and (c) the polycaprolactone has an average molecular weight of about 400 g/mol to about 10,000 g/mol. The disclosure further provides methods of making the polycaprolactone compositions, polycaprolactones, compositions including the same, and methods of making and using the same.

Abstract: An inspection unit for cans (11), in particular for metal cans used in metered dose inhalers or for the manufacture of batteries, comprising a visual inspection unit (9) comprising camera units (20), a conveying unit (8), wherein images of the individual cans are captureable by different camera units from different viewing angles, wherein the camera units each capture a plurality of cans simultaneously in an image comprising a plurality of image portions (24) including images of an outer surface portion of each of said plurality of cans from a different viewing angle, the image portions including images of outer side surface portions (22) and the outer bottom surface portion (19) of each can, the sum of the images of the outer side surface portions covering the entire outer side surface of the can; and a processing unit to process the captured images portions and to determine an inspection result.

Abstract: A rigid foam comprising the reaction product of an (poly)isocyanate, and a polyethercarbonate polyol copolymer is described. The polyethercarbonate polyol copolymer is derived from the copolymerisation of one or more epoxides with CO2, wherein the total —CO2— content of the polyethercarbonate polyol copolymer is between 1 and 40 wt %, the carbonate linkages are <95% of the total linkages from the copolymerisation, and the molecular weight is between 100 to 5000 g/mol. The foam is a polyurethane foam, more typically, a polyisocyanurate or a mixed polyisocyanurate/polyurethane foam. Methods, polyols and compositions for producing the foams are also described.

Abstract: An inspection unit for cans (11), in particular for metal cans used in metered dose inhalers or for the manufacture of batteries, comprising a visual inspection unit (9) comprising camera units (20), a conveying unit (8), wherein images of the individual cans are captureable by different camera units from different viewing angles, wherein the camera units each capture a plurality of cans simultaneously in an image comprising a plurality of image portions (24) including images of an outer surface portion of each of said plurality of cans from a different viewing angle, the image portions including images of outer side surface portions (22) and the outer bottom surface portion (19) of each can, the sum of the images of the outer side surface portions covering the entire outer side surface of the can; and a processing unit to process the captured images portions and to determine an inspection result.

Abstract: The present invention relates to novel substituted azetidine dihydrothienopyridines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I)

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed. In particular, methods, apparatus devices and or/or systems for enumerating rooted partial subtrees are disclosed.

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed. In particular, methods, apparatus devices and or/or systems for analyzing hierarchical data are disclosed.

Abstract: The present invention relates to a compound according to formula (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g., dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

Abstract: A grounding clamp is provided. The grounding clamp comprises a body portion having first and second sides, first and second fingers extending from the first side of the body portion, a first set of teeth extending from the first side of the body portion, the first set of teeth positioned between the first and second fingers, and a second set of teeth extending from the second side of the body portion.

Abstract: The invention provides a process for preparing an aqueous pharmaceutical solution of calcium gluconate. The process comprises the steps of: (i) mixing calcium gluconate, calcium saccharate and water at a mixing temperature of 60-100° C. to form a bulk solution; (ii) filling portions of the bulk solution into containers at a filling temperature of 60-100° C.; and (iii) sealing the containers with a closure. The invention also provides a batch of containers obtainable by this process.

Abstract: The present invention relates to a compound according to formula (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g., dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed. In particular, methods, apparatus devices and or/or systems for analyzing hierarchical data are disclosed.

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed. In particular, methods, apparatus devices and or/or systems for enumerating rooted partial subtrees are disclosed.

Abstract: The present invention relates to novel substituted azetidine dihydrothienopyridines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I)

Abstract: The invention provides a process for preparing an aqueous pharmaceutical solution of calcium gluconate. The process comprises the steps of: (i) mixing calcium gluconate, calcium saccharate and water at a mixing temperature of 60-100° C. to form a bulk solution; (ii) filling portions of the bulk solution into containers at a filling temperature of 60-100° C.; and (iii) sealing the containers with a closure. The invention also provides a batch of containers obtainable by this process.

Abstract: A grounding clamp is provided. The grounding clamp comprises a body portion having first and second sides, first and second fingers extending from the first side of the body portion, a first set of teeth extending from the first side of the body portion, the first set of teeth positioned between the first and second fingers, and a second set of teeth extending from the second side of the body portion.

Abstract: The present disclosure relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The disclosure further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed.

Abstract: Embodiments of methods, apparatuses, devices and/or systems for manipulating hierarchical sets of data are disclosed. In particular, methods, apparatus devices and or/or systems for enumerating rooted partial subtrees are disclosed.

Abstract: The present disclosure relates to compounds according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The disclosure further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.